Patents by Inventor Susan Elizabeth Morgan-Lappe

Susan Elizabeth Morgan-Lappe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11045480
    Abstract: The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their uses to treat patients having cancer.
    Type: Grant
    Filed: December 13, 2018
    Date of Patent: June 29, 2021
    Assignees: AbbVie Inc., AbbVie Biotherapeutics Inc.
    Inventors: Kurt C. Gish, Jonathan A. Hickson, Susan Elizabeth Morgan-Lappe, James W. Purcell
  • Publication number: 20190105328
    Abstract: The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their uses to treat patients having cancer.
    Type: Application
    Filed: December 13, 2018
    Publication date: April 11, 2019
    Inventors: Kurt C. GISH, Jonathan A. HICKSON, Susan Elizabeth MORGAN-LAPPE, James W. PURCELL
  • Publication number: 20190105329
    Abstract: The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their uses to treat patients having cancer.
    Type: Application
    Filed: December 13, 2018
    Publication date: April 11, 2019
    Inventors: Kurt C. GISH, Jonathan A. HICKSON, Susan Elizabeth MORGAN-LAPPE, James W. PURCELL
  • Publication number: 20190099431
    Abstract: The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their uses to treat patients having cancer.
    Type: Application
    Filed: December 11, 2018
    Publication date: April 4, 2019
    Inventors: Kurt C. GISH, Jonathan A. HICKSON, Susan Elizabeth MORGAN-LAPPE, James W. PURCELL
  • Patent number: 10195209
    Abstract: The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their uses to treat patients having cancer.
    Type: Grant
    Filed: November 29, 2016
    Date of Patent: February 5, 2019
    Assignees: AbbVie Inc., AbbVie Biotherapeutics Inc.
    Inventors: Kurt C. Gish, Jonathan A. Hickson, Susan Elizabeth Morgan-Lappe, James W. Purcell
  • Patent number: 10188660
    Abstract: The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their uses to treat patients having cancer.
    Type: Grant
    Filed: November 29, 2016
    Date of Patent: January 29, 2019
    Assignees: AbbVie Inc., AbbVie Biotherapeutics Inc.
    Inventors: Kurt C. Gish, Jonathan A. Hickson, Susan Elizabeth Morgan-Lappe, James W. Purcell
  • Publication number: 20170151343
    Abstract: The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their uses to treat patients having cancer.
    Type: Application
    Filed: November 29, 2016
    Publication date: June 1, 2017
    Inventors: Kurt C. GISH, Jonathan A. Hickson, Susan Elizabeth Morgan-Lappe, James W. Purcell
  • Publication number: 20170151344
    Abstract: The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their uses to treat patients having cancer.
    Type: Application
    Filed: November 29, 2016
    Publication date: June 1, 2017
    Inventors: Kurt C. GISH, Jonathan A. Hickson, Susan Elizabeth Morgan-Lappe, James W. Purcell